Evidence-based Complementary and Alternative Medicine · 2017 · 15 citations · 35 references
MedicineMedicinal ChemistryPharmacologyExperimental PharmacologyNeuropharmacologyPharmacodynamicsMedicinal Plant KnowledgeMedicinal PlantsNeuroprotectionNeuroprotective PharmacologyAnticonvulsant ActionAnticonvulsant TreatmentBioactive ConstituentsIntraperitoneal AdministrationMalondialdehyde FormationNeuroprotective MechanismsPlant Extract AntioxidantsTotal Phenolic Content
Anticonvulsant and neuroprotective activity of Phragmanthera austroarabica extract were tested in pentylenetetrazole‐kindled mice. All the chemical constituents of the plant extract were identified. Additionally, the extract was standardized and proved to contain total phenolic contents equal to 379.92 ± 1.32 mg gallic acid equivalents/g dry plant extract. Induction of kindling was achieved by repeated intraperitoneal administration of pentylenetetrazole (35 mg/kg) twice weekly. Male albino mice were given P . austroarabica extract (200, 400, or 800 mg/kg). The two higher doses (400 or 800 mg/kg) of the extract significantly caused notable reduction in seizure activity and hippocampal malondialdehyde level compared to pentylenetetrazole control group. The highest dose enhanced cortical GSH level and showed intact DNA in the laddering assay. Upon studying the neuroprotective effect, mice treated with the higher dose of the extract demonstrated an improvement in the percent of surviving neurons in the cortex and hippocampus. We concluded that P. austroarabica extract ameliorated seizure activity and protected cortical and hippocampal neurons against pentylenetetrazole‐induced kindling in mice.
35
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Akihiko Nunomura, George Perry, Gjumrakch Aliev et al. · Journal of Neuropathology & Experimental Neurology · 2001 · 1.9K citations · Full text
Theory and Practice of Histological Techniques
R N MacSween · Journal of Clinical Pathology · 1977 · 1K citations · Full text